Marisa K. Kilgour
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Efficacy of chimeric antigen receptor engineered natural killer cells in the treatment of hematologic malignancies: a systematic review and meta-analysis of preclinical studies.
Journal: Cytotherapy
Published: September 05, 2024
Thermoneutral housing does not accelerate metabolic dysfunction-associated fatty liver disease in male or female C57Bl/6J mice fed a Western diet.
Journal: American journal of physiology. Endocrinology and metabolism
Published: May 17, 2023
Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy.
Journal: Frontiers in immunology
Published: February 14, 2023
Assessing the Immune Regulatory Role of Metabolites In Vitro.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 31, 2022
Clinically relevant T cell expansion media activate distinct metabolic programs uncoupled from cellular function.
Journal: Molecular therapy. Methods & clinical development
Published: October 08, 2021
1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer.
Journal: Science advances
Published: July 31, 2020
Natural Killer Cell IFNγ Secretion is Profoundly Suppressed Following Colorectal Cancer Surgery.
Journal: Annals of surgical oncology
Published: January 25, 2018
Understanding lymphocyte metabolism for use in cancer immunotherapy.
Journal: The FEBS journal
Published: October 03, 2017
Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery.
Journal: International journal of molecular sciences
Published: July 25, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026